StockData
Becton Dickinson & Co logo

Becton Dickinson & Co (BDX) stock

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3018% above fair value
$215.42−1.05 (-0.49%)

Close on Nov 17, 2026Market cap $58.68BP/E 65.1Yield 1.93%

Earnings

Becton Dickinson's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 8, 2027
Q1 FY2027 · estimated, before the open
Revenue, Q4 FY2026
$5.30B
-10.2% on a year earlier
adjusted diluted EPS, Q4 FY2026
$4.15
$3.96 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Becton Dickinson's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q1 FY2027ended Dec 31, 2026Feb 8, 2027Expected–––––
Q4 FY2026ended Sep 30, 2026Nov 5, 2026before the open$5.30B-10.2%$2.52$4.15Release
Q3 FY2026ended Jun 30, 2026Aug 6, 2026before the open$4.98B–$1.37$3.23Release
Q2 FY2026ended Mar 31, 2026Apr 2, 2026during market hours––––Release
Q1 FY2026ended Dec 31, 2025Feb 9, 2026before the open$5.25B+1.0%$1.34$2.91Release
Q4 FY2025ended Sep 30, 2025Nov 6, 2025before the open$5.90B+8.5%$1.72$3.96Release
Q3 FY2025ended Jun 30, 2025Aug 7, 2025before the open––––Release
Q2 FY2025ended Mar 31, 2025May 1, 2025before the open$5.30B+6.0%$1.07$3.35Release
Q1 FY2025ended Dec 31, 2024Feb 5, 2025during market hours$5.20B+10.6%––Release
Q4 FY2024ended Sep 30, 2024Nov 7, 2024before the open$5.44B+6.6%$1.45$3.81Release
Q3 FY2024ended Jun 30, 2024Aug 1, 2024before the open$5.00B+2.0%$1.68$3.50Release
Q2 FY2024ended Mar 31, 2024May 2, 2024before the open$5.00B+4.2%$1.85$3.17Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Becton Dickinson's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Adjusted Diluted EPSnon-GAAPFY2026$14.75 – $15.05–NewNov 6, 2025
Adjusted Diluted EPSnon-GAAPFY2027$13.10 – $13.30–NewNov 5, 2026

Guidance history

Every forecast Becton Dickinson put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted Diluted EPSFY2027$13.10 – $13.30New
Aug 6, 2026Adjusted Diluted EPSFY2026$12.62 – $12.72Raised
Feb 9, 2026Adjusted Diluted EPSFY2026$12.35 – $12.65New
Nov 6, 2025Adjusted Diluted EPSFY2026$14.75 – $15.05New
May 1, 2025Adjusted Diluted EPSFY2025$14.06 – $14.34New
May 1, 2025organic revenue growthFY2025+3% – +3.5%New
May 1, 2025revenuesFY2025$21.80B – $21.90BNew
Feb 5, 2025Adjusted Diluted EPSFY2025$14.30 – $14.60Raised
Nov 7, 2024Adjusted Diluted EPS GrowthFY2025+8.5% – +11%New
Nov 7, 2024Adjusted Diluted EPSFY2025$14.25 – $14.60New
Nov 7, 2024GAAP Revenue GrowthFY2025+8.9% – +9.4%New
Nov 7, 2024Adjusted Revenue Growth (FXN)FY2025+8.8% – +9.3%New
Nov 7, 2024Organic Revenue Growth (FXN)FY2025+4% – +4.5%Lowered
Nov 7, 2024GAAP RevenuesFY2025$21.90B – $22.10BNew
Aug 1, 2024adjusted diluted EPSFY2024$13.05 – $13.15Raised
Aug 1, 2024GAAP revenue growthFY2024+3.7%New
Aug 1, 2024organic revenue growthFY2024+5% – +5.25%Lowered
May 2, 2024Adjusted Diluted EPSFY2024$12.95 – $13.15Raised
May 2, 2024Organic Revenue Growth (FXN)FY2024+5.5% – +6.25%Reaffirmed
May 2, 2024Total RevenuesFY2024$20.10B – $20.30BLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Becton Dickinson filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Results
  6. Update
  7. Results
  8. News
  9. News
  10. News
  11. Update
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?